(r)-3-hydroxybutyl (r)-3-hydroxybutyrate
Small moleculeexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
2
Phase 4
0
Earliest trial started Dec 31, 2020 (NCT04616781)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06426134 | N/A | Jul 31, 2024 | The University of Texas, Dallas, University of Alberta, University of Amsterdam |
| NCT05778695 | N/A | Mar 9, 2023 | Farmer Foundation, University of Michigan |
| NCT05015881 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2021 | University of Pennsylvania |
| NCT04616781 | Phase 2/Phase 3 (Phase 3) | Dec 31, 2020 | National Institute on Alcohol Abuse and Alcoholism (NIAAA), University of Pennsylvania |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pennsylvania | Academic/Hospital | 2 | 2 | 1 | 2020 |
| Farmer Foundation | Academic/Hospital | 1 | 0 | 1 | 2023 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Government | 1 | 0 | 1 | 2020 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Alberta | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Amsterdam | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2023 |
7 organizations
Page 1 / 1